ZA859706B - Organic compounds and their pharmaceutical use - Google Patents

Organic compounds and their pharmaceutical use

Info

Publication number
ZA859706B
ZA859706B ZA859706A ZA859706A ZA859706B ZA 859706 B ZA859706 B ZA 859706B ZA 859706 A ZA859706 A ZA 859706A ZA 859706 A ZA859706 A ZA 859706A ZA 859706 B ZA859706 B ZA 859706B
Authority
ZA
South Africa
Prior art keywords
organic compounds
pharmaceutical use
alkylene
chem
salts
Prior art date
Application number
ZA859706A
Other languages
English (en)
Inventor
Stephen Richard Baker
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of ZA859706B publication Critical patent/ZA859706B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA859706A 1984-12-20 1985-12-19 Organic compounds and their pharmaceutical use ZA859706B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848432144A GB8432144D0 (en) 1984-12-20 1984-12-20 Organic compounds

Publications (1)

Publication Number Publication Date
ZA859706B true ZA859706B (en) 1986-10-29

Family

ID=10571475

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859706A ZA859706B (en) 1984-12-20 1985-12-19 Organic compounds and their pharmaceutical use

Country Status (9)

Country Link
EP (1) EP0186426B1 (de)
JP (1) JPS61155374A (de)
AT (1) ATE56443T1 (de)
AU (1) AU576926B2 (de)
CA (1) CA1261339A (de)
DE (1) DE3579682D1 (de)
GB (2) GB8432144D0 (de)
IE (1) IE58327B1 (de)
ZA (1) ZA859706B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143931A (en) * 1982-06-24 1992-09-01 Smithkline Beecham Corporation Leukotriene antagonists containing tetrazolyl groups
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
GB8709546D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Pharmaceutical use of organic compounds
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3480796D1 (de) * 1983-02-18 1990-01-25 Allied Signal Inc Verfestigung von polyaethylenfasernetzwerken.
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
ATE56443T1 (de) 1990-09-15
EP0186426A3 (en) 1987-09-02
IE853230L (en) 1986-06-20
IE58327B1 (en) 1993-09-08
GB8432144D0 (en) 1985-01-30
DE3579682D1 (de) 1990-10-18
EP0186426B1 (de) 1990-09-12
JPS61155374A (ja) 1986-07-15
EP0186426A2 (de) 1986-07-02
AU576926B2 (en) 1988-09-08
GB8531160D0 (en) 1986-01-29
CA1261339A (en) 1989-09-26
AU5132185A (en) 1986-06-26
GB2168704A (en) 1986-06-25
GB2168704B (en) 1988-06-22

Similar Documents

Publication Publication Date Title
DE3669503D1 (de) Oberflaechenaktive n-(omega, omega-1-dialkoxy)- und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,n-trisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.
IL74223A0 (en) Carbamate compounds,compositions,and methods of making the same
EP0614913A3 (de) Dynorphin Derivate.
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ZA859706B (en) Organic compounds and their pharmaceutical use
EP0288969A3 (en) Antiulcer composition
FI95247C (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
SE8600046D0 (sv) Use of an ester compound as a temporary bactericide and product containing said ester compound
DE3876712D1 (de) Antianaerobe naphthyridinverbindungen.
GB8829593D0 (en) Novel compounds
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease
GB8709547D0 (en) Organic compounds
DE3479421D1 (de) Dibenzopyran derivatives
ATE65986T1 (de) Propanolabkoemmlinge.
DE3464598D1 (en) Acetylene derivatives having an enzyme-inhibiting activity, their preparation and their use as medicines
ES2055094T3 (es) Utilizacion de poliaminas oxidadas, en particular nn'-bis-(3-propionaldehido)-1-4-diaminobutano (dialdehido espermina) como agentes inmunosupresores.
IL106934A0 (en) Heteroarenylpiperazines,a process for their preparation and their use as medicaments